GlassScriptPhysician profile
David Parrella
NPI 1225233141
$5,496.46
in general payments reported to CMS, 2019-2025
11 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2021: $800 · 2022: $402 · 2023: $3,100 · 2024: $539 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Food and Beverage | $1,482.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,725.48 | 2021-2025 | Red 72 |
| Medtronic, INC. | $673.09 | 2023-2024 | Pipeline, Solitaire X |
| Imperative Care, INC | $491.76 | 2021-2024 | Zoom 88-T Large Distal Platform |
| Stryker Corporation | $358.17 | 2021-2023 | Universal Neuro 3 |
| Phenox INC. | $354.73 | 2021-2022 | |
| Depuy Synthes Sales INC. | $287.18 | 2021-2025 | Tfn-Advance, Na, Cerebase |
| Balt USA, LLC | $173.16 | 2023 | |
| Medtronic USA, INC. | $145.34 | 2019 | |
| Microvention, INC. | $142.99 | 2019 | |
| Amgen INC. | $123.39 | 2019 | |
| Qapel Medical INC | $21.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parrella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.